Abstract:To our knowledge, this is the first study to identify a peptide (named as "TAP1") that specifically binds with PSA−/lo prostate cancer cells.TAP1 inhibited PCa growth both in vitro and in vivo.TAP1 also improved the anti-tumor effect of the anti-androgens and chemotherapeutic agents in vitro.The effects of TAP1 might at least in part by shortening the lengths of telomeres and decreasing the expression of HOXB9 and TGF-β2.Our results indicated that therapeutic peptides that specifically target prostate cancer stem cell might be a very valuable and promising approach to overcome chemoresistance and prevent recurrence in patients with PCa.Patients with prostate cancer (PCa) will eventually progress to castrate-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT) treatment. Prostate-specific antigen (PSA)−/lo cells which harbor self-renewing long-term tumor-propagating cells that can be enriched using ALDH+CD44+α2β1+ and can initiate tumor development may represent a critical source of CRPC cells. Our purpose was to find a peptide that specifically targets PSA−/lo PCa cells to retard the development of CRPC. PSA+ and PSA−/lo cells were successfully separated from LNCaP xenograft tumors after prostate- PSAP-GFP vector infection and FACS. A variety of PSA−/lo cells specifically targeting peptide (named as "TAP1" targeted affinity peptide 1) was identified by using phage display library screening. The highest binding rate in TAP1 binding cell subpopulations are identified to be among ALDH+CD44+CXCR4+CD24+ cells. TAP1 significantly inhibited PCa growth both in vitro and in vivo. TAP1 significantly improved the anti-proliferation effect of the anti-androgens (Charcoal dextran-stripped serum (CDSS)+Bicalutamide, Enzalutamide) and chemotherapeutic agents (Abiraterone, Docetaxel, Etoposide) in vitro. TAP1 treatment shortens the length of telomeres in ALDH+CD44+CXCR4+CD24+ cells and significantly reduces the expression of Homeobox B9 (HOXB9) and TGF-β2. In conclusion, PSA−/lo PCa cell-specific targeting peptide (TAP1) that suppressed PCa cell growth both in vitro and in vivo and improved the drug sensitivities of anti-androgens and chemotherapeutic agents at least through shortening the length of telomere and reducing the expression of HOXB9 and TGF-β2. Therapeutic peptides that specifically target prostate cancer stem cell might be a very valuable and promising approach to overcome chemoresistance and prevent recurrence in patients with PCa.

α-Tocopherol-associated Protein Suppresses Prostate Cancer Proliferation by Phosphoinositide 3-Kinase Pathway

Α-Tocopherol-associated Protein Suppresses Prostate Cancer Proliferation by Phosphoinositide 3-Kinase Pathway

Effect of Α-Tocopherol Associated Protein in the Regulation of the Apoptosis Induced by Oxidative Stress in Prostate Cancer Cells

Expression of A-Tocopherol-associated Protein (TAP) is Associated with Clinical Outcome in Breast Cancer Patients.

Reduced Expression of Tocopherol-Associated Protein (TAP/Sec14L2) in Human Breast Cancer

Abstract 5247: Δ-Tocopherol Inhibits the Development of Prostate Adenocarcinoma in Prostate Specific Pten-/- Mice

A naturally occurring mixture of tocotrienols inhibits the growth of human prostate tumor, associated with epigenetic modifications of cyclin-dependent kinase inhibitors p21 and p27

TROAP Regulates Prostate Cancer Progression Via the WNT3/survivin Signalling Pathways

Potent Inhibitory Effect of δ-Tocopherol on Prostate Cancer Cells Cultured in Vitro and Grown As Xenograft Tumors in Vivo

Phage display screening identifies a prostate specific antigen (PSA)–/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancer

Vitamin D, Intermediary Metabolism and Prostate Cancer Tumor Progression

Effect of Vitamin K3 on Proliferation of Prostate Cancer Cells by the Regulation of Ras Signal Pathway

BAP1 Suppresses Prostate Cancer Progression by Deubiquitinating and Stabilizing PTEN

Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes

[Tanshinone reverses androgen deprivation-induced invasion of prostate cancer cells by suppressing PI3K and AKT signaling pathways]

A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands

alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.

CTRP3 Stimulates Proliferation and Anti-Apoptosis of Prostate Cells through PKC Signaling Pathways

Silencing TTK Expression Inhibits the Proliferation and Progression of Prostate Cancer.

PTPN14 Acts As a Candidate Tumor Suppressor in Prostate Cancer and Inhibits Cell Proliferation and Invasion Through Modulating LATS1/YAP Signaling.

Involvement of PD-L1-mediated Tumor-Intrinsic Signaling and Immune Suppression in Tumorigenic Effect of Α-Tocopherol.